FIB-4 as a screening and disease monitoring method in pre-fibrotic stages of metabolic dysfunction-associated fatty liver disease (MASLD)
Stewart G. Albert, Emily M. Wood
Topics & Concepts
MedicinePioglitazoneSteatohepatitisInternal medicineFibrosisFatty liverGastroenterologySteatosisDiabetes mellitusAlanine transaminasePlaceboAspartate transaminaseDiseaseEndocrinologyPathologyType 2 diabetesAlkaline phosphataseBiochemistryChemistryAlternative medicineEnzymeLiver Disease Diagnosis and TreatmentLiver Disease and TransplantationNutrition and Health in Aging